MD
Pediatrix Medical Group, Inc.
26.00$
-0.4%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 18.1% | 21.8% | 19.7% | 21.5% | 25.4% | 29.7% | 24.7% | 29.2% | 32.6% | 34.0% | 28.4% | 31.0% | |
| 0.9% | 3.3% | 0.4% | 1.0% | 5.0% | 10.7% | 5.0% | 10.7% | 15.5% | 16.7% | 9.9% | 13.6% | |
| 5.4% | 8.0% | 5.3% | 6.7% | 10.6% | 16.2% | 11.0% | 16.6% | 21.1% | 22.2% | 15.9% | 19.0% | |
| 11.9% | 12.6% | 13.3% | 13.7% | 13.9% | 12.7% | 12.7% | 11.7% | 10.7% | 10.8% | 11.4% | 11.2% | |
| 0.5% | 0.6% | 0.0% | – | – | – | – | – | – | – | – | – | |
| 6.3% | – | – | – | 4.7% | 3.6% | 3.9% | 3.7% | 3.4% | 3.3% | – | – | |
| 65.9% | 62.4% | 64.3% | 62.1% | 59.7% | 57.7% | 62.3% | 59.1% | 57.1% | 56.1% | 61.3% | 59.5% | |
| 0.7% | 1.0% | 0.9% | 0.5% | 0.6% | 0.5% | 0.5% | 0.4% | 0.7% | 0.8% | 0.8% | 0.7% | |
| 58.4% | 61.8% | 60.5% | 64.6% | 64.7% | 64.5% | 60.4% | 60.3% | 59.5% | 61.5% | 57.6% | 58.6% | |
| 15.1% | 17.5% | 11.4% | 15.5% | 18.0% | 20.2% | 13.6% | 16.2% | 17.8% | 20.4% | 21.4% | 23.5% | |
| 1.6% | 1.6% | 1.7% | 1.8% | 1.7% | 1.5% | 1.7% | 1.7% | 1.7% | 1.7% | 9.9% | 9.3% | |
| 1.4% | 1.6% | 1.5% | 1.6% | 2.3% | 2.2% | 2.2% | 2.0% | 1.8% | 1.7% | 1.5% | 14.2% | |
| 26.7% | 27.6% | 32.0% | 30.7% | 29.2% | 27.6% | 29.6% | 27.8% | 26.2% | 25.4% | 19.2% | 18.7% | |
| 41.6% | 38.2% | 39.5% | 35.4% | 35.3% | 35.5% | 39.6% | 39.7% | 40.5% | 38.5% | 42.4% | 41.4% | |
| -1.1% | -6.7% | -6.7% | -15.0% | -13.4% | -11.5% | -11.4% | -9.0% | -5.3% | -3.7% | -2.6% | -0.6% | |
| 3.6% | 3.8% | 3.8% | 4.2% | 4.1% | 4.0% | 4.3% | 4.1% | 3.9% | 3.8% | 4.0% | 3.8% |
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.